Representing Kansas bioscience companies and research institutions
Home About KansasBio Membership Center Bioscience News Contact KansasBio
Information Resources Education & Training Networking & Collaboration Business & Investment

 

Up-to-the minute latest news in the biotechnology sector and from biotech companies in Kansas and around the world

  KansasBio photos  

Search:

Biotechnology Headlines from PR Newswire


HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
Valtech Cardio Treats First Mitral Regurgitation Patients with Percutaneous Annuloplasty Device Without Open-Heart Surgery
BioTrinity Ventures to the Capital
ThromboGenics Business Update
Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
Medigus: Successful Three-Year Follow-Up Data of the SRS™ Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando
InspireMD Announces Reimbursement Coverage for MGuard™ Coronary Embolic Protection Stent (EPS) From Brazil's Largest Private Insurer
UCB and IBM Collaborate to Personalize Care for Epilepsy Patients
HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013
The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
Breakthrough Method for Lipid Analysis in Fecal Material Developed; New Understanding of Diseases/Disorders Related to Gut Function Possible
Strategic move to strengthen Consumer Care business: Bayer to acquire Steigerwald Arzneimittelwerk GmbH
Active Life Announces $500K Follow On Series A Investment - Tech Coast Angels Re-up
InspireMD Announces Reimbursement Coverage for MGuard™ Coronary Embolic Protection Stent (EPS) from Brazil’s Largest Private Insurer
DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
Asmacure to Present Four Posters on Novel Pulmonary Development Compound ASM-024 at American Thoracic Society 2013 International Conference
Access Pharmaceuticals Reports First Quarter Results
NW Bio Initiates Phase III DCVax®-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open
TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events
AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin Antibodies
MultiCell Technologies Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice
Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
Ambit Biosciences Announces Pricing of Initial Public Offering
Biosensors to Acquire Assets of Spectrum Dynamics
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts
Cancer Vaccine Partnering Terms and Agreements
RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer
Global Biometrics and Border Control Award for DERMALOG
NIH Saves Lives: Fred Hutchinson Cancer Research Center Calls On Congress To Restore Full NIH Funding
CCS Medical Moves Forward as Medicare Winner
AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society of Clinical Oncology Annual Meeting
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
Arno Therapeutics to Present Positive, New Data Supporting the Potential of Onapristone in Endometrial and Breast Cancers at ASCO 2013 Annual Meeting
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
Metabolic Solutions Development Company announces publication of data describing a new drug target for diabetes
Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against Dr. Yamanaka for Deception Spanish Portuguese
Dyadic International Reports First Quarter 2013 Financial Results
Vermillion Reports First Quarter 2013 Results
XBiotech Announces Results for its XILONIX™ Treatment of Non-Small Cell Lung Cancer (NSCLC)
Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines
Advancing Preclinical Predictions, Making Faster Clinical Decisions with Cancer Models and Preclinical Imaging - World Pharma Congress this June in Philadelphia
Veloxis Pharmaceuticals announces financial results for the first three months of 2013
Bayer Receives U.S. FDA Approval for Xofigo® (radium Ra 223 dichloride) Injection as a New Treatment for Castration-Resistant Prostate Cancer with Bone Metastases
Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
Art Pappas Elected to NVCA Board of Directors

< Prev Next >
PR Newswire - United Business Media
 



Kansas Bioscience Association

© 2004 Kansas Bioscience Organization (KansasBio). All rights reserved.